inobrodib
cellcentric
['inobrodib', 'multiple myeloma']
cellcentric at #eha2023. sharing further data, inobrodib, first-in-class p300/cbp inhibitor, treating rr multiple myeloma. hall 3, p863, 6pm. see: 
Inobrodib (CCS1477): first-in-class p300/CBP small molecule inhibitor drug, to treat specific cancers.